RNAi-mediated silencing of ABCD3 gene expression in rat C6 glial cells: A model system to study PMP70 function

Neurochemistry International

Volumn 52, Issue 6, 2008, Pages 1106-1113

  Di Benedetto, Rita ^a   Denti, Michela Alessandra ^b   Salvati, Serafina ^a   Sanchez, Massimo ^a   Attorri, Lucilla ^a   David, Giulia ^a   Di Biase, Antonella ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF TRENTO   (Italy)

Author keywords

ABC transporters; ABCD3 (PMP70); Adrenoleukodystrophy; Peroxisome; RNA interference

Indexed keywords

ADRENOLEUKODYSTROPHY PROTEIN; BIOCHEMICAL MARKER; LIGNOCERIC ACID; MESSENGER RNA; PALMITIC ACID; PMP70 PROTEIN; PROTEIN; PUROMYCIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ABCD3 GENE; ADRENOLEUKODYSTROPHY; ANALYTIC METHOD; ANIMAL CELL; ARTICLE; BRAIN DAMAGE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOFLUOROMETRY; FATTY ACID ANALYSIS; FATTY ACID OXIDATION; GENE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GLIA CELL; LIPID ANALYSIS; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PLASMID; PRIORITY JOURNAL; RAT; RNA INTERFERENCE; X CHROMOSOME LINKED DISORDER;

ADRENOLEUKODYSTROPHY; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM; DOWN-REGULATION; FATTY ACIDS; GENE SILENCING; LIPID PEROXIDATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MODELS, BIOLOGICAL; MYELIN SHEATH; NEUROGLIA; OXIDATIVE STRESS; RATS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

MAMMALIA; RATTUS;

EID: 40949116751     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.11.007     Document Type: Article

References (39)

1. Asheuer M., Bieche I., Laurendeau I., Moser A., Hainque B., Vidaud M., and Aubourg P. Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy. Hum. Mol. Gen. 14 (2005) 1293-1303
2. Baumgart E., Vanhorebeek I., Grabenbauer M., Borgers M., Declercq P.E., Fahimi H.D., and Baes M. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (Pex5 knockout mouse). Am. J. Pathol. 159 (2001) 1477-1494
3. Berger J., and Gärtner J. X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects. Biochim. Biophys. Acta 1763 (2006) 1721-1732
4. Berger J., Albet S., Bentejac M., Netik A., Holzinger A., Roscher A.A., Bugaut M., and Forss-Petter S. The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression. Eur. J. Biochem. 265 (1999) 719-727
5. Braiterman L.T., Zheng S., Watkins P.A., Geraghty M.T., Johnson G., McGuinness M.C., Moser A.B., and Smith K.D. Suppression of peroxisomal membrane protein defects by ATP-binding cassette (ABC) proteins. Hum. Mol. Genet. 7 (1998) 239-247
6. Chelli B., Lena A., Vanacore R., Da Pozzo E., Costa B., Rossi L., Salvetti A., Scatena F., Ceruti S., Abbracchio M.P., Gremigni V., and Martini C. Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells. Biochem. Pharmacol. 68 (2004) 125-134
7. De Angelis F.G., Sthandier O., Berarducci B., Toso S., Galluzzi G., Ricci E., Cossu G., and Bozzoni I. Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in delta 48-50 DMD cells. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 9456-9461
8. Denti M.A., Rosa A., Sthandier O., De Angelis F.G., and Bozzoni I. A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells. Mol. Ther. 10 (2004) 191-199
9. Di Biase A., Salvati S., and Serlupi Crescenzi G. Analysis of brain and myelin lipids by high-performance thin layer chromatography and densitometry. Neurochem. Res. 14 (1989) 153-156
10. Flavigni E., Sanhay A., Aubourg P., and Cartier N. Retroviral mediated adrenoleukodystrophy-related gene transfer corrects very long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts: implication for therapy. FEBS Lett. 448 (1999) 261-264
11. Gärtner J., Moser H., and Valle D. Mutations in the 70 K peroxisomal membrane protein gene in Zellweger syndrome. Nat. Genet. 1 (1992) 16-23
12. Guimarães C.P., Domingues P., Aubourg P., Fouquet F., Pujol A., Jimenez-Sanchez G., Sá-Miranda C., and Azevedo J.E. Mouse liver PMP70 and ALDP homomeric interactions prevail in vivo. Biochim. Biophys. Acta 1689 (2004) 235-243
13. Hannon G.J. RNA interference. Nature 418 (2002) 244-251
14. Hillebrand M., Verrier S.E., Ohlenbusch A., Schafer A., Soling H.D., Wouters F.S., and Gartner J. Homo- and hetero-dimerization of two human peroxisomal ABC transporters, the adrenoleukodystrophy protein (ALDP, ABCD1) and PMP70 (ABCD3). J. Biol. Chem. 282 (2007) 26997-27005
15. Imanaka T., Aihara K., Takano T., Yamashita A., Sato R., Suzuki Y., Yokota S., and Osumi T. Characterization of the 70-kDa peroxisomal membrane protein, an ATP-binding cassette transporter. J. Biol. Chem. 274 (1999) 11968-11976
16. Kashiwayama Y., Asahina K., Shibata H., Morita M., Muntau A.C., Roscher A.A., Wanders R.J., Shimozawa N., Sakaguchi M., Kato H., and Imanaka T. Role of Pex19p in the targeting of PMP70 to peroxisome. Biochim. Biophys. Acta 1746 (2005) 116-128
17. Krause C., Rosewich H., Thanos M., and Gärtner J. Identification of novel mutations in PEX2, PEX6, PEX10, PEX12, and PEX13 in Zellweger spectrum patients. Hum. Mutat. 27 (2006) 1157
18. Liu L.X., Janvier K., Berteaux-Lecellier V., Cartier N., Benarous R., and Aubourg P. Homo- and hetero-dimerization of peroxisomal ATP-binding cassette half-transporters. J. Biol. Chem. 274 (1999) 32738-32743
19. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., and Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8 (2002) 500-508
20. Lu J.F., Lawler A.M., Watkins P.A., Powers J.M., Moser A.B., Moser H.W., and Smith K.D. A mouse model for X-linked adrenoleukodystrophy. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 9366-9371
21. McGuinness M.C., Lu J.F., Zhang H.P., Dong G.X., Heinzer A.K., Watkins P.A., Powers J., and Smith K.D. Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy. Mol. Cell. Biol. 23 (2003) 744-753
22. Morgenstern J.P., and Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18 (1990) 3587-3596
23. Morrison M.L., Williamson K., Arthur K., Price G.J., Hamilton P.W., and Maxwell P. Phenotypic changes in mitochondrial membrane potential (delta psi(m)) during valinomycin-induced depolarisation and apoptosis. Cell. Oncol. 27 (2005) 231-236
24. Moser H., Dubey P., and Fatemi A. Progress in X-linked adrenoleukodystrophy. Curr. Opin. Neurol. 17 (2004) 263-269
25. Moser H.W., Mahmood A., and Raymond G.V. X-linked adrenoleukodystrophy. Nat. Clin. Pract. Neurol. 3 (2007) 140-151
26. Mosser J., Douar A.M., Sarde C.O., Kioschis P., Feil R., Moser H., Poustka A.M., Mandel J.L., and Aubourg P. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361 (1993) 726-730
27. Mosser J., Lutz Y., Stoeckel M.E., Sarde C.O., Kretz C., Douar A.M., Lopez J., Aubourg P., and Mandel J.L. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum. Mol. Genet. 3 (1994) 265-271
28. Netik A., Forss-Petter S., Holzinger A., Molzer B., Unterrainer G., and Berger J. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy (X-ALD) protein deficiency: implications for therapy. Hum. Mol. Genet. 8 (1999) 907-913
29. Petriv O.I., Pilgrim D.B., Rachubinski R.A., and Titorenko V.I. RNA interference of peroxisome-related genes in C. elegans: a new model for human peroxisomal disorders. Physiol. Genom. 10 (2002) 79-91
30. Portsteffen H., Beyer A., Becker E., Epplen C., Pawlak A., Kunau W.H., and Dodt G. Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders. Nat. Genet. 17 (1997) 449-452
31. Powers J.M., DeCiero D.P., Cox C., Richfield E.K., Ito M., Moser A.B., and Moser H.W. The dorsal root ganglia in adrenomyeloneuropathy: neuronal atrophy and abnormal mitochondria. J. Neuropathol. Exp. Neurol. 60 (2001) 493-501
32. Pujol A., Ferrer I., Camps C., Metzger E., Hindelang C., Callizot N., Ruiz M., Pàmpols T., Giròs M., and Mandel J.L. Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy. Hum. Mol. Genet. 13 (2004) 2997-3006
33. Sacktor N.C., Griffin J., Moser A.B., and Moser H.W. Effects of subperineurial injections of very long-chain and medium-chain fatty acids into rat sciatic nerve. Neurochem. Pathol. 5 (1986) 71-83
34. Schröder J.M., Mayer M., and Weis J. Mitochondrial abnormalities and intrafamilial variability of sural nerve biopsy findings in adrenomyeloneuropathy. Acta Neuropathol. 92 (1996) 64-69
35. Sharp P.A. RNAi and double-strand RNA. Gene Dev. 13 (1999) 139-141
36. Tanaka A.R., Tanabe K., Morita M., Kurisu M., Kasiwayama Y., Matsuo M., Kioka N., Amachi T., Imanaka T., and Ueda K. ATP binding/hydrolysis by phosphorylation of peroxisomal ATP-binding cassette proteins PMP70 (ABCD3) and adrenoleukodystrophy protein (ABCD1). J. Biol. Chem. 277 (2002) 40142-40147
37. Wanders R.J.A., Denis S., Ruiter J.P.N., Schutgens R.B.H., van Roermund C.W.T., and Jacobs B.S. Measurement of peroxisomal fatty acid beta oxidation in cultured human skin fibroblasts. J. Inherit. Metab. Dis. 18 Suppl. 1 (1995) 113-124
38. Wanders R.J.A., Visser W.F., van Roermund C.W.T., Kemp S., and Waterham H.R. The peroxisomal ABC transporter family. Pflugers Arch. 453 (2007) 719-734
39. Wilson R., and Sargent J.R. Lipid fatty acid composition of brain tissue from adrenoleukodystrophy patients. J. Neurochem. 61 (1993) 290-297